ABM Respiratory Care Announces $14.8M Series B

 Gunderson Dettmer represented client ABM Respiratory Care (ABMRC), a medical technology company, in its $14.8 million Series B financing led by Peter Soderberg, ABMRC’s Chairman of the Board and Managing Partner of Worthy Venture Resources, with participation from Bluwave Capital. ABMRC is focused on developing and globally commercializing novel airway clearance and ventilation solutions. The new capital will be used to accelerate the rollout of BiWaze® Clear, ABM Respiratory Care's latest airway clearance system designed for both hospital and home use, by scaling U.S. sales efforts, investing in clinical research, and enhancing patient engagement and digital health capabilities.

In the announcement of the transaction, CEO of ABMRC Greg Miller said, “This investment marks a pivotal moment for ABM Respiratory Care as we expand access to our respiratory therapy platform and bring transformative solutions into more homes and hospitals. We're grateful for the support of our new and existing investors who are excited about our vision for intelligent, connected therapies of people struggling to breathe.”

The Gunderson deal team included Marcia Hatch and Jenny Whalen-Ball.

Companies
ABM Respiratory Care
Bluwave Capital